• Supportive Oncodermatology: Managing Skin, Hair, and Nail Toxicities in Cancer Care

  • Jan 21 2025
  • Length: 10 mins
  • Podcast

Supportive Oncodermatology: Managing Skin, Hair, and Nail Toxicities in Cancer Care

Listen for free

View show details

  • Summary

  • Synopsis: Adverse reactions involving the skin, nails, and hair are common among patients undergoing treatment for cancer and are often underreported and overlooked. These reactions directly impact patient quality of life and may be the reason for interruptions in lifesaving antineoplastic treatment. To address these toxicities, the Association of Cancer Care Centers (ACCC) is leading an initiative that aims to educate providers and other cancer care team members about the optimal management of dermatologic side effects. In this episode, CANCER BUZZ speaks with Julie Ryan Wolf, PhD, MPH and C.J.G. (Corina) van den Hurk, PhD, the chair and vice chair of the Oncodermatology Study Group at the Multinational Association of Supportive Care in Cancer (MASCC) about common oncodermatological toxicities including radiation dermatitis, hair loss, and nail changes unique to EGFR-inhibitors. Also discussed are strategies to increase provider collaboration to intervene at an early stage to improve quality of life for patients receiving cancer treatment. “If we have symptom monitoring on a regular basis throughout the course of treatment, we’ll be able to intervene sooner… helping improve [patient] quality of life” – Julie Ryan Wolf, PhD, MPH “In effect, almost each patient has a dermatologic side effect at the end of the treatment, or has experienced that during the treatment, and they are all very interfering.” – CJG (Corina) van den Hurk, PhD Julie Ryan Wolf, PhD, MPH Chair, Oncodermatology Study Group Multinational Association of Supportive Care in Cancer (MASCC) Associate Professor, Department of Dermatology, Department of Radiation Oncology University of Rochester Medical Center Rochester, NY CJG (Corina) van den Hurk, PhD Vice Chair, Oncodermatology Study Group Multinational Association of Supportive Care in Cancer (MASCC) Senior Researcher, Santeon Hospitals Netherlands    Thank you to Johnson & Johnson for their support of this program. Additional Reading/Sources   Multinational Association of Supportive Care in Cancer (MASCC) Home Multinational Association of Supportive Care in Cancer (MASCC) Oncodermatology Study Group MASCC Study Group Evidence-Based Clinical Practice Guidelines ACCC Supportive Care Strategies for Dermatologic Toxicities Related to Cancer Therapies Oncology Issues – Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies Dermatologic Adverse Events of Systemic Anticancer Therapies: Cytotoxic Chemotherapy, Targeted Therapy, and Immunotherapy Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors Supportive oncodermatology-a narrative review of its utility and the way forward =
    Show More Show Less
Show More Show Less

What listeners say about Supportive Oncodermatology: Managing Skin, Hair, and Nail Toxicities in Cancer Care

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available